This announcement is a separate document:
メディネット：（開示事項の経過）台湾規制当局が新たな医療機関でのγδT細胞療法の提供を承認（Medigen Biotechnology Corp.とのライセンス契約の進捗）
Medinet: (Progress of disclosure matters) **** regulatory authorities have approved the provision of γδT cell therapy at new medical institutions (progress of licensing agreement with Medigen Biotechnology Corp.)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.